| ATCC 29176| Ruminococcus lactaris| Ruminococcus lactaris Moore et al. 1976
Gut microbiota composition: Ruminococcus bacteria are commonly found in the gastrointestinal tract of humans and animals, where they play important roles in digestion, fermentation, and overall gut health. They are known for their ability to degrade complex carbohydrates, particularly cellulose and hemicellulose, into simpler compounds like short-chain fatty acids (SCFAs), which can be utilized by the host.
Fermentation and SCFA production: Ruminococcus species contribute to the fermentation of dietary fibers and complex carbohydrates in the colon. This fermentation process produces SCFAs, including acetate, propionate, and butyrate. SCFAs have various health benefits, such as providing energy to colonocytes, regulating immune function, maintaining gut barrier integrity, and influencing metabolic processes.
Potential health implications: While specific information about Ruminococcus lactaris is limited, other Ruminococcus species have been implicated in both positive and negative health outcomes. For example, alterations in the abundance or composition of Ruminococcus species have been associated with conditions such as inflammatory bowel diseases (IBD), obesity, metabolic syndrome, and colorectal cancer. However, the exact role of Ruminococcus lactaris in these conditions, if any, remains to be elucidated.
Host-microbe interactions: Ruminococcus bacteria interact with the host immune system and other members of the gut microbiota, influencing overall gut homeostasis and health. These interactions can have both local effects within the gut and systemic effects throughout the body.
A lot more information is available when you are logged in and raise the display level
Other Sources for more information:
Statistics | NCBI | Data Punk | End Products Produced |
Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.
Lab | Frequency | UD-Low | UD-High | KM Low | KM High | Lab Low | Lab High | Mean | Median | Standard Deviation | Box Plot Low | Box Plot High | KM Percentile Low | KM Percentile High |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Labs | 2.74 | 0 | 0 | 70 | 17700 | 0 | 11149 | 3030.8 | 1514 | 4142 | 0 | 5960 | 0 %ile | 100 %ile |
thorne | 34.48 | 1 | 4 | 0 | 5 | 2.2 | 2 | 1.2 | 1 | 4 | 8.3 %ile | 83.3 %ile | ||
thryve | 80.51 | 0 | 1866 | 28 | 4557 | 0 | 18977 | 2958.4 | 460 | 8172.6 | 0 | 5357 | 11.2 %ile | 90.5 %ile |
ubiome | 0.25 | 308 | 376 | 248 | 436 | 342 | 342 | 48.1 | 308 | 376 | 25 %ile | 50 %ile |
Source of Ranges | Low Boundary | High Boundary | Low Boundary %age | High Boundary %age |
---|
Lab | Frequency Seen | Average | Standard Deviation | Sample Count | Lab Samples |
---|---|---|---|---|---|
bugspeak | 100 % | 0.086 % | % | 1.0 | 1 |
CerbaLab | 100 % | 0.715 % | 0.914 % | 3.0 | 3 |
CosmosId | 78.125 % | 0.314 % | 0.471 % | 25.0 | 32 |
custom | 6.557 % | 0.473 % | 0.284 % | 4.0 | 61 |
es-xenogene | 3.448 % | 1.524 % | % | 1.0 | 29 |
Microba | 3.571 % | 0.24 % | % | 1.0 | 28 |
SequentiaBiotech | 75 % | 0.203 % | 0.166 % | 27.0 | 36 |
Thorne | 12.5 % | 0 % | 0 % | 13.0 | 104 |
Thryve | 80.576 % | 0.376 % | 1.085 % | 1120.0 | 1390 |
Tiny | 100 % | 0.029 % | 0.029 % | 2.0 | 2 |
uBiome | 0.253 % | 0.034 % | 0.005 % | 2.0 | 792 |
|
And display level must be raised above public.
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.